Contineum Therapeutics

(NASDAQ) CTNM

Current Price$14.10

Market Cap$511.59M

Since IPO (2024)-8%

5 YearN/A

1 Year+245%

1 Month+5%

Contineum Therapeutics Financials at a Glance

Market Cap

$511.59M

Revenue (TTM)

$0.00

Net Income (TTM)

$59.98M

EPS (TTM)

$-2.18

P/E Ratio

-6.05

Dividend

$0.00

Beta (Volatility)

0.56 (Low)

Dividend

$0.00

Beta (Volatility)

0.56 (Low)

Price

$14.10

Volume

541,148.35

Open

$13.20

Price

$14.10

Volume

541,148.35

Open

$13.20

Previous Close

$14.15

Daily Range

$12.84 - $14.53

52-Week Range

$3.35 - $16.33

Dividend

$0.00

Beta (Volatility)

0.56 (Low)

Price

$14.10

Volume

541,148.35

Open

$13.20

Previous Close

$14.15

Daily Range

$12.84 - $14.53

52-Week Range

$3.35 - $16.33

CTNM News

Contineum (CTNM) Q2 R&D Jumps 78%

Motley Fool Markets TeamAug 5, 2025

CTNM: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Contineum Therapeutics

Industry

Pharmaceuticals

Sector

Health Care

Employees

CEO

Carmine N. Stengone, MBA

Website

www.contineum-tx.com

Headquarters

San Diego, CA 92121, US

CTNM Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

-26%

Return on Capital

-26%

Return on Assets

-22%

Earnings Yield

-16.53%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$511.59M

Shares Outstanding

38.76M

Volume

541.15K

Avg. Volume

283.44K

Financials (TTM)

Gross Profit

$323.00K

Operating Income

$68.06M

EBITDA

$68.06M

Operating Cash Flow

$55.31M

Capital Expenditure

$231.00K

Free Cash Flow

$55.54M

Cash & ST Invst.

$262.90M

Total Debt

$8.25M

Contineum Therapeutics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$85.00K

N/A

Gross Margin

0.00%

N/A

Market Cap

$511.59M

N/A

Market Cap/Employee

$12.48M

N/A

Employees

N/A

Net Income

$15.16M

-4.1%

EBITDA

$17.03M

-17.5%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Net Cash

$254.65M

+28.3%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$5.91M

+22.9%

Short Term Debt

$2.34M

+61.2%

Return on Assets

-21.68%

N/A

Return on Invested Capital

-25.50%

N/A

Free Cash Flow

$13.08M

-26.2%

Operating Cash Flow

$13.04M

-27.8%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

LXEOLexeo Therapeutics, Inc. Common Stock

LXEOLexeo Therapeutics, Inc. Common Stock$5.80+0.52%

CADLCandel Therapeutics, Inc.

CADLCandel Therapeutics, Inc.$7.53+16.38%

KYTXKyverna Therapeutics, Inc.

KYTXKyverna Therapeutics, Inc.$9.00+1.47%

SLNSilence Therapeutics plc

SLNSilence Therapeutics plc$7.29+2.24%

ACIUAC Immune S.A.

ACIUAC Immune S.A.$3.05+2.35%

AMRNAmarin Corporation plc

AMRNAmarin Corporation plc$14.24+1.21%

ANROAlto Neuroscience, Inc.

ANROAlto Neuroscience, Inc.$25.19+1.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

CNSPCns Pharmaceuticals

CNSPCns Pharmaceuticals$7.84+2.39%

GBTGGlobal Business Travel Group

GBTGGlobal Business Travel Group$9.34+0.58%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.18+0.01%

PLTRPalantir Technologies

PLTRPalantir Technologies$146.03+0.01%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.69-0.00%

SOFISoFi Technologies

SOFISoFi Technologies$16.20-0.01%

IBITiShares Bitcoin Trust

IBITiShares Bitcoin Trust$45.40+0.02%

Questions About CTNM

What is the current price of Contineum Therapeutics?

Contineum Therapeutics is trading at $14.15 per share.

What is the 52-week range for Contineum Therapeutics?

Over the past 52 weeks, Contineum Therapeutics has traded between $3.35 and $16.33.

How much debt does Contineum Therapeutics have?

As of the most recent reporting period, Contineum Therapeutics reported total debt of $8.25M.

How much cash does Contineum Therapeutics have on hand?

Contineum Therapeutics reported $75.60M in cash and cash equivalents in its most recent financial results.

What is Contineum Therapeutics’s dividend yield?

Contineum Therapeutics does not currently have a dividend yield.

Contineum Therapeutics

Contineum Therapeutics Financials at a Glance

CTNM News

Contineum (CTNM) Q2 R&D Jumps 78%

CTNM: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Contineum Therapeutics

CTNM Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Contineum Therapeutics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About CTNM

What is the current price of Contineum Therapeutics?

What is the 52-week range for Contineum Therapeutics?

How much debt does Contineum Therapeutics have?

How much cash does Contineum Therapeutics have on hand?

What is Contineum Therapeutics’s dividend yield?

Premium Investing Services